Toxicokinetics in the evaluation of toxicity data
PG Watanabe, AM Schumann, RH Reitz - Regulatory Toxicology and …, 1988 - Elsevier
Toxicokinetics provides a powerful tool, which is not used sufficiently in the conduct and
interpretation of animal toxicity studies. In selecting doses for toxicity studies toxicokinetic …
interpretation of animal toxicity studies. In selecting doses for toxicity studies toxicokinetic …
[引用][C] Application of pharmacokinetics and biopharmaceutics in the design of toxicological studies
RD Smyth, GH Hottendorf - Toxicology and Applied Pharmacology, 1980 - Elsevier
The objective of this article is to present a multidisciplined approach in the design of
toxicological studies involving the areas of pharmaceutical sciences, drug metabolism, and …
toxicological studies involving the areas of pharmaceutical sciences, drug metabolism, and …
Toxicokinetics
A Roberts, AG Renwick - Hayes' Principles and Methods of …, 2014 - books.google.com
The principles of pharmacokinetics apply to any environmental nonnutrient (xenobiotic), and
many of the biological processes involved in the absorption, distribution, and elimination …
many of the biological processes involved in the absorption, distribution, and elimination …
The importance of pharmacokinetic/toxicokinetic and metabolic information in carcinogenicity study design
LF Chasseaud - Drug Information Journal, 1992 - journals.sagepub.com
A major challenge in the risk/benefit assessment of new chemical entities is the rational and
reliable extrapolation of preclinical (nonclinical) safety evaluation data from animals to …
reliable extrapolation of preclinical (nonclinical) safety evaluation data from animals to …
Concomitant toxicokinetics: techniques for and interpretation of exposure data obtained during the conduct of toxicology studies
AM Dahlem, SR Allerheiligen… - Toxicologic …, 1995 - journals.sagepub.com
Toxicokinetic analyses have become a routine component of preclinical toxicology studies
with pharmaceutical candidates. Evaluation of plasma and/or tissue samples from animals …
with pharmaceutical candidates. Evaluation of plasma and/or tissue samples from animals …
Design of toxicokinetic studies
DA Smith, MJ Humphrey, C Charuel - Xenobiotica, 1990 - Taylor & Francis
1. Toxicokinetics is defined as pharmacokinetic studies in animals during actual toxicity
studies or under conditions mimicking them (species, duration, dose level, etc.). 2 …
studies or under conditions mimicking them (species, duration, dose level, etc.). 2 …
[PDF][PDF] Application of pharmacokinetic principles in practice
PJ Gehring, JD Young - Proceedings of the Eighth Annual Conference …, 1977 - apps.dtic.mil
The objective of a toxicological study is to elucidate the untoward effects of a chemical,
qualitatively and, quantitatively. The ultimate goal to be realized from acquisition of this …
qualitatively and, quantitatively. The ultimate goal to be realized from acquisition of this …
Differences between pharmacokinetics and toxicokinetics
PG Welling - Toxicologic pathology, 1995 - journals.sagepub.com
Pharmacokinetics has evolved into a highly interactive discipline in which the dispositional
characteristics of an administered drug are often compared to the time course of observed …
characteristics of an administered drug are often compared to the time course of observed …
Toxicokinetics in long-term toxicity and carcinogenicity studies
G Bode - Drug information journal, 1994 - journals.sagepub.com
Drug development is a dynamic process requiring toxicokinetics to keep pace with the
progression and results of nonclinical and clinical studies. Toxicokinetics should thus be …
progression and results of nonclinical and clinical studies. Toxicokinetics should thus be …
Considerations in the design of toxicokinetic programs
MN Cayen - Toxicologic pathology, 1995 - journals.sagepub.com
The objectives of toxicokinetic (TK) studies are to evaluate systemic exposure of the toxicity
species to drug and/or metabolite (s) and to relate exposure to dose level and toxicological …
species to drug and/or metabolite (s) and to relate exposure to dose level and toxicological …